﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Fri, 03 Apr 2026 21:58:24 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/November-2025/rss/3857</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/November-2025/rss/3857" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Trending Topics]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-34</link><description><![CDATA[  APhA Staff  

 Can baxdrostat reduce systolic BP in patients with hypertension? 

   

 It is widely known that aldosterone dysregulation plays a significant role in hard-to-control ...]]></description><pubDate>Mon, 06 Oct 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-34</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3651]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Finerenone with empagliflozin may improve CKD for patients with T2D]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/finerenone-with-empagliflozin-may-improve-ckd-for-patients-with-t2d</link><description><![CDATA[  Elizabeth Briand  

   

 More than one out of every 10 Americans has diabetes, according to CDC. For these millions of individuals, their condition puts them at high risk of developing CKD, ...]]></description><pubDate>Mon, 06 Oct 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/finerenone-with-empagliflozin-may-improve-ckd-for-patients-with-t2d</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3652]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[NSAIDs could pose CVD risk to patients with gout]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/nsaids-could-pose-cvd-risk-to-patients-with-gout</link><description><![CDATA[  Aiya Almogaber, PharmD  

   

 Patients with gout who were given NSAIDs to prevent flare-ups when starting allopurinol faced a higher risk of serious heart problems than those given colchicine ...]]></description><pubDate>Mon, 06 Oct 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/nsaids-could-pose-cvd-risk-to-patients-with-gout</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3653]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Experts recommend tailored inhaled therapy for stable COPD]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/experts-recommend-tailored-inhaled-therapy-for-stable-copd</link><description><![CDATA[  Aiya Almogaber, PharmD  

   

 A major update to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines includes a more personalized approach to inhaled therapy in ...]]></description><pubDate>Mon, 06 Oct 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/experts-recommend-tailored-inhaled-therapy-for-stable-copd</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3654]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Guideline details slow, personalized approach to benzodiazepine tapers]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/guideline-details-slow-personalized-approach-to-benzodiazepine-tapers</link><description><![CDATA[  Jen Hand  

   

 How should clinicians safely discontinue benzodiazepine medications when continued use presents greater risks than benefits? A new joint clinical practice guideline from 10 ...]]></description><pubDate>Mon, 06 Oct 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/guideline-details-slow-personalized-approach-to-benzodiazepine-tapers</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3655]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Meta-analysis finds nuance in risks attributed to haloperidol]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/meta-analysis-finds-nuance-in-risks-attributed-to-haloperidol</link><description><![CDATA[  Kevin Willmann  

   

 A meta-analysis of mostly short-term studies published in the June 2025 issue of  PLOS One  found no increased mortality with haloperidol use, nor that the drug was ...]]></description><pubDate>Mon, 06 Oct 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/meta-analysis-finds-nuance-in-risks-attributed-to-haloperidol</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3656]]></dc:identifier></item></channel></rss>